.

Pharmaceutical Business Intelligence

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Doxylamine succinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for doxylamine succinate?

Doxylamine succinate is the generic ingredient in eight branded drugs marketed by Copley Pharm, Quantum Pharmics, Sanofi Aventis Us, Pfizer, Par Pharm, LNK, Chattem, Perrigo, Actavis Labs Fl Inc, and Duchesnay, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for doxylamine succinate. Thirty suppliers are listed for this compound.

Summary for Generic Name: doxylamine succinate

Tradenames:8
Patents:3
Applicants:10
NDAs:12
Drug Master File Entries: see list13
Suppliers / Packagers: see list30
Bulk Api Vendors: see list39
Clinical Trials: see list58
Patent Applications: see list604
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:doxylamine succinate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lnk
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL040564-001Aug 27, 2004OTCNoNo► Subscribe► Subscribe
Duchesnay
DICLEGIS
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL021876-001Apr 8, 2013RXYesYes7,560,122► SubscribeY ► Subscribe
Sanofi Aventis Us
DECAPRYN
doxylamine succinate
TABLET;ORAL006412-014Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Duchesnay
DICLEGIS
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL021876-001Apr 8, 2013RXYesYes6,340,695► SubscribeY ► Subscribe
Sanofi Aventis Us
DECAPRYN
doxylamine succinate
TABLET;ORAL006412-015Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc